Poseida Therapeutics | IPO Presentation Deck | 34 slides · page 30 of 34
The slide contrasts the persistence of integrated transposons versus the clearance of non-integrated AAV following liver cell replication.
Pitch deck · solution · present_solution · balanced density
Slide locked Sign in to view
Slide schematic 4/4
callout 1/1 diagram 1/1 image 1/1 title 1/1
Components 4
primary process photo headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1